LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)
$0.14 0 (0%)
Analysed LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) News Sources
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
15-10-2025
yahoo.com
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
18-09-2025
yahoo.com
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
27-08-2025
yahoo.com
Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth
24-07-2025
yahoo.com
Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome
30-06-2025
yahoo.com
Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets
25-06-2025
yahoo.com
What is the current price of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The current price of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is $0.14.
LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) since the previous trading day is $0.
LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The most recent average sentiment score for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The most recent sentiment for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is .
SEC-8K** Filing Available For LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.